Authors: Slavin, S Ackerstein, A Morecki, S Gelfand, Y Cividalli, G

Citation: S. Slavin et al., Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes, BONE MAR TR, 28(8), 2001, pp. 795-798

Authors: Slavin, S Nagler, A Panigrahi, S Varadi, G Ackerstein, A Samuel, S Or, R

Citation: S. Slavin et al., Shifting towards better immunotherapy rather than more intensive chemoradiotherapy using a non-myeloablative approach in patients with leukemia, HEMAT BLOOD, 40, 2001, pp. 674-677

Authors: Nagler, A Ackerstein, A Or, R Naparstek, E Slavin, S

Citation: A. Nagler et al., Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation, EXP HEMATOL, 28(11), 2000, pp. 1225-1231

Authors: Toren, A Nagler, A Rozenfeld-Granot, G Levanon, M Davidson, J Bielorai, B Kaplinsky, C Meitar, D Mandel, M Ackerstein, A Ballin, A Attias, D Biniaminov, M Rosenthal, E Brok-Simoni, F Rechavi, G Kaufmann, Y

Citation: A. Toren et al., Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma, TRANSPLANT, 70(7), 2000, pp. 1100-1104

Authors: Vourka-Karussis, U Ackerstein, A Pugatsch, T Slavin, S

Citation: U. Vourka-karussis et al., Allogeneic cell-mediated immunotherapy for eradication of minimal residualdisease: Comparison of T-cell and IL-2 activated killer (LAK) cell-mediated adoptive immunotherapy in murine models, EXP HEMATOL, 27(3), 1999, pp. 461-469

Authors: Nagler, A Ackerstein, A Kapelushnik, J Or, R Naparstek, E Slavin, S

Citation: A. Nagler et al., Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease, BONE MAR TR, 24(3), 1999, pp. 339-342